Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 38

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 38
---
'>17</div>

| Listing                      |     | Our common stock trades on The Nasdaq Capital Market under the symbol “SXTP.”                                                                                                                                                                                                                                                                                                                                              
 There is no established public trading market for the Pre-Funded Warrants or the Warrants and we do not expect a market to develop. In addition, we do not intend to apply to list the Pre-Funded Warrants or the Warrants on any national securities exchange or other nationally recognized trading system. Without an active trading market, the liquidity of the Pre-Funded Warrants and the Warrants will be limited. |
| Risk Factors                 |     | You should carefully consider the information set forth in this prospectus and, in particular, the specific factors set forth in the “Risk Factors” section beginning on page 19 of this prospectus and the risk factors in our most recent Annual Report on Form 10-K before deciding whether or not to invest in our securities.                                                                                         |
| Transfer Agent and registrar |     | Equity Stock Transfer, LLC                                                                                                                                                                                                                                                                                                                                                                                                 |
| Reasonable best efforts      |     | The placement agent has agreed to use its reasonable best efforts to                                                                                                                                                                                                                                                                                                                                                       
 arrange for the sale of the securities offered by this prospectus. The placement agent is not purchasing or selling any of the securities                                                                                                                                                                                                                                                                                  
 we are offering and the placement agent is not required to arrange the purchase or sale of any specific number of securities or dollar                                                                                                                                                                                                                                                                                     
 amount. See “Plan of Distribution” on page 34 of this prospectus.                                                                                                                                                                                                                                                                                                                                                          |
| Dividend Policy              |     | We have never declared or paid any cash dividends on our shares of common stock. We do not anticipate paying any cash dividends in the foreseeable future.                                                                                                                                                                                                                                                                 |

| (1) | The number of shares of common                                                                                                        
 stock to be outstanding after this offering is based on 1,472,891 shares of Common Stock outstanding as of July 2, 2025 and excludes: |

| ● | 57,068 shares of common stock                     
 reserved for future issuance under the 2022 Plan; |

| ● | 2,127,070 shares of common                                                                                     
 stock issuable upon exercise of outstanding warrants at a weighted average exercise price of $15.85 per share; |

| ● | 137,637 shares of common stock                                                                              
 issuable upon exercise of outstanding options at a weighted average exercise price of $13.92 per share; and |

| ● | shares of common stock issuable                                   
 upon the conversion of 76,